RHOU
Rho-related GTP-binding protein RhoU
Also known as: ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, RHOU_HUMAN, WRCH-1, WRCH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7L0Q8
- Gene
- RHOU
- Ensembl
- ENSG00000116574
- Chromosome
- 1
- Canonical length
- 258 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Microtubules,Primary cilium
OverviewNCBI Gene
This gene encodes a member of the Rho family of GTPases. This protein can activate PAK1 and JNK1, and can induce filopodium formation and stress fiber dissolution. It may also mediate the effects of WNT1 signaling in the regulation of cell morphology, cytoskeletal organization, and cell proliferation. A non-coding transcript variant of this gene results from naturally occurring read-through transcription between this locus and the neighboring DUSP5P (dual specificity phosphatase 5 pseudogene) locus.[provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
258 residues, UniProt reviewed canonical sequence.
>Q7L0Q8|RHOU
1 MPPQQGDPAF PDRCEAPPVP PRRERGGRGG RGPGEPGGRG RAGGAEGRGV KCVLVGDGAV
61 GKTSLVVSYT TNGYPTEYIP TAFDNFSAVV SVDGRPVRLQ LCDTAGQDEF DKLRPLCYTN
121 TDIFLLCFSV VSPSSFQNVS EKWVPEIRCH CPKAPIILVG TQSDLREDVK VLIELDKCKE
181 KPVPEEAAKL CAEEIKAASY IECSALTQKN LKEVFDAAIV AGIQYSDTQQ QPKKSKSRTP
241 DKMKNLSKSW WKKYCCFVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RHOU can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 67 nTPM
- hippocampal formation: 48 nTPM
- midbrain: 44 nTPM
- basal ganglia: 42 nTPM
- skeletal muscle: 39 nTPM
- amygdala: 35 nTPM
Single-cell type
- oligodendrocytes: 189 nCPM
- oligodendrocyte progenitor cells: 40 nCPM
- papillary tip epithelial cells: 35 nCPM
- astrocytes: 31 nCPM
- ependymal cells: 19 nCPM
- bergmann glia: 16 nCPM
Immune cell
- MAIT T-cell: 0.8 nTPM
- memory CD8 T-cell: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
- eosinophil: 0.4 nTPM
- gdT-cell: 0.4 nTPM
- myeloid DC: 0.4 nTPM
Brain region
- white matter: 68 nTPM
- basal ganglia: 54 nTPM
- thalamus: 50 nTPM
- midbrain: 49 nTPM
- medulla oblongata: 44 nTPM
- cerebral cortex: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 0.95
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- cytoskeleton organization
- endocytosis
- establishment of cell polarity
- G1/S transition of mitotic cell cycle
- positive regulation of focal adhesion disassembly
- positive regulation of protein targeting to mitochondrion
- Rac protein signal transduction
- regulation of cell shape
- regulation of small GTPase mediated signal transduction
- signal transduction
Molecular functions
- GTP binding
- GTPase activity
- guanyl-nucleotide exchange factor activity
- metal ion binding
- protein kinase binding
- protein-macromolecule adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RHOU in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RHOU as an antibody target. Whether an autoantibody or antibody against RHOU could matter depends on whether native RHOU is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RHOU is annotated at the cell surface, where native RHOU is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RHOU as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...